Medical Journals

Differential Activation of Human Gingival Epithelial Cells and Monocytes by Porphyromonas Gingivalis Fimbriae.

Authors:
  • Eskan Mehmet A
  • Hajishengallis George
  • Kinane Denis F

From: University of Louisville School of Dentistry, 501 South Preston Street, Room 204, Louisville, KY 40292, USA.

Infection and immunity

  • Publish Date: Feb 2007
  • ISSN: 0019-9567
  • Volume: 75
  • Issue: 2
  • Pages: 892-8
  • Medium: Print
  • Language: English
  • Citation (JAMA): Eskan Mehmet A, Hajishengallis George, Kinane Denis F, et al. Differential Activation of Human Gingival Epithelial Cells and Monocytes by Porphyromonas Gingivalis Fimbriae.. Infect. Immun. Feb 2007;75:892-8

Abstract

Humans develop periodontitis in response to challenge by microbial dental plaque. Inflammation begins after perturbation of gingival epithelial cells by subgingival bacteria interacting through pattern-recognition receptors, including the Toll-like receptors (TLR). Porphyromonas gingivalis is a major periodontopathogen that interacts with epithelial cells through its cell surface fimbriae (FimA), leading to colonization and/or invasion. Previous work by our group has established membrane CD14 as an essential coreceptor for TLR2-mediated activation of transfected cell lines by P. gingivalis FimA. We have shown that gingival epithelial cells express TLR2 but not CD14 on their cell surfaces. We thus speculated that P. gingivalis FimA does not readily activate epithelial innate immune responses but rather functions to promote P. gingivalis colonization in the absence of a vigorous FimA-induced response. This hypothesis was verified by the findings that primary human gingival epithelial cells responded poorly to FimA in terms of interleukin (IL)-6, IL-8, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor alpha responses, in stark contrast to the marked response to other TLR2 agonists (Pam3Cys, FSL-1) that are not strictly dependent on CD14. On the other hand, CD14-expressing human primary monocytes responded with high levels of the same cytokines to both FimA and the control TLR2 agonists. The gingival epithelial cells failed to respond to FimA even in the presence of exogenously added soluble CD14. These data indicate that the gingival epithelial cell hyporesponsiveness to FimA is attributable to the lack of membrane-expressed but not soluble CD14. In conclusion, P. gingivalis FimA differentially activates human monocytes and epithelial cells, perhaps reflecting different tactics used by P. gingivalis when interacting with different host cell types or a host strategy to limit inflammation.

Mesh Headings (Keywords): Antigens, CD14, Cells, Cultured, Diglycerides, Epithelial Cells, Fimbriae, Bacterial, Gingiva, Granulocyte-Macrophage Colony-Stimulating Factor, Humans, Immunologic Factors, Interleukin-6, Interleukin-8, Monocytes, Oligopeptides, Porphyromonas gingivalis, Toll-Like Receptor 2, Tumor Necrosis Factor-alpha


Check for Full Text / PubMed Unique Identifier (PMID): 17118977


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.